Chardan Capital maintains Rocket Pharmaceuticals Buy, $11 target
Chardan Capital maintained Rocket Pharmaceuticals at Buy, keeping its $11.00/share price target, according to TradingView News ratings actions.
Ratings actions GMT) Rocket Pharmaceuticals Is Maintained at Buy by Chardan CapitalRatings actions